mRNA |
clofarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.2 |
3e-10 |
mRNA |
3-Cl-AHPC |
CTRPv2 |
pan-cancer |
AAC |
-0.19 |
1e-07 |
mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
2e-07 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
2e-07 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.19 |
3e-07 |
mRNA |
MLN4924 |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
7e-07 |
mRNA |
PF-184 |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
2e-06 |
mRNA |
MST-312 |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
2e-06 |
mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
3e-06 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
4e-06 |